An improved, reliable and practical kinetic assay for the detection of prekallikrein activator in blood products

Archives of Pharmacal Research

Volumn 25, Issue 4, 2002, Pages 505-510

  In, Soo Shin ^a   Yun, Bo Shim ^a   Choong, Man Hong ^a   Hyun, Chul Koh ^b   Seok, Ho Lee ^a   Seung, Hwa Hong ^a  

^a Korea Food and Drug Administration   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Hypotension; Kinetic Assay; Prekallikrein Activator

Indexed keywords

AMIDASE; BLOOD CLOTTING FACTOR 12A; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; SODIUM CHLORIDE;

ARTICLE; BLOOD ANALYSIS; DOSE RESPONSE; HUMAN; KINETICS; PH; REPRODUCIBILITY; STANDARD;

AMIDOHYDROLASES; BLOOD CHEMICAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR XIIA; HUMANS; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; KINETICS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SODIUM CHLORIDE;

EID: 0036691781     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02976610     Document Type: Article

References (33)

1. Allen, P., Kaplan, M. D., Kusumam, J. and Michael, S., Pathways for bradykinin formation and inflammatory disease. J. Allerg. Clin. Immun., 109(2), 195-209 (2002).
2. Alving, B. M., Hojima, Y., Pisano, J. J., Mason, B. L., Buckingham, R. E., Mozen, M. M. and Finlayson, J. S., Hypotension associated with prekallikrein activator (Hageman-factor fragments) plasma protein fraction. N. Engl. J. Med., 229, 66-70 (1978).
3. Alving, B. M., Tankersley, D. L., Mason, B. L., Rossi, F., Aronson, D. L. and Finlayson, J. S., Contact-activated factors: contaminants of immunoglobulin preparations with coagulant and vasoactive properties. J. Lab. Clin. Med., 96, 334-346 (1980).
4. Bagdasarian, A., Talamo R. C., and Colman, R. W., Simple assay for prekallikrein activators. Immunol. Commun., 2(1), 93-103 (1973).
5. Council of Europe. European Pharmacopoeia, 3rd edition; p. 95, (1997).
6. Domenico, R., Anna, R., and Girolamo, C., Pharmacology of the kallikrein-kinin system. Pharmacol. Res., 35(6), 513-515 (1997).
7. Friberger, P., Gnos, M., Gustavsson, S., Laurell, L. and Claeson, G., A new specific substrate for the determination of plasmin activity. In Scully, M. F. and Kakkar, V. V. (Eds.): Chromogenic peptide substrates: chemistry and clinical usage. Churchill Livingstone, Edinburgh London and New York, pp. 121-127, (1978).
8. Griffin, J. H., Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII). Proc. Natl. Acad. Sci., 75(4), 1998-2002 (1978).
9. Hannele T. and Suomela. H., An optimized assay for prekallikrein activator activity in human plasma products. Thromb. Res., 27(1), 35-44 (1982).
10. Heinonen, J., Peltola, K., Himberg, J. J. and Suomela, H., Vasodilator effect of plasma protein fraction correlates with prekallikrein activator activity. Ann. Thorac. Surg., 33(3), 244-249 (1982).
11. Heinonen, J., Peltola, K., Himberg, J.J., and Suomela, H., Hypotensive effect of prekallikrein activator (PKA) in plasma protein fraction (PPF). Develop. Biol. Standard, 48, 129-130 (1981).
12. Judith, C., Annie, M., Shen, Y. and Andrew, H., Kallikreins and kinins in inflammatory-like events in the reproductive tract. Pharmacol. Res., 35(6), 537-540 (1997).
13. Kaplan, A. P. and Austen, K. F., A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J. Exp. Med., 133(4), 696-712 (1971).
14. Kaplan, A. P., and Austen, K. F., A pre-albumin activator of prekallikrein. J. Immunol., 105(4), 802-811 (1970).
15. Kaplan, A. P., Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, Hageman factor, prekallikrein, high molecular weight kininogen, and factor XI. Prog. Hemost. Thromb., 4, 127-75 (1978).
16. Kaplan, A. P., Kay, A. B. and Austen, K. F., A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J. Exp. Med., 135(1), 81-97 (1972).
17. Kerry, P. J., Curtis, A. D., Catherine, J., and Thomas, D. P., Standardization of prekallikrein activator (PKA): the 1st British Reference Preparation for PKA. British J. Haematol., 52, 275-281 (1982).
18. Kuwahara, S. S., Prekallikrein activator (Hageman factor fragment) in human plasma fraction. Transfusion, 20, 433-439 (1980).
19. Lüben, G., Quast, U. and Geiger, H., Prekallikrein activator levels and side effects with human albumin preparations. Develop. Biol. Standard, 48, 123-127 (1981).
20. Lundbland, J. L., In vitro assay for prekallikrein activator (PKA). Develop. Biol. Standard, 44, 107-114 (1979).
21. Mandle, R. J., Colman, R. W., and Kaplan, A. P., Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc. Natl. Acad. Sci., 73(11), 4179-4183 (1976).
22. Marley, P. B. and Gilbo, C. M., Temperature sensitivity within the pasteurization temperature range of prekallikrein activator in stable plasma protein solution (SPPS). Transfusion, 21, 320-324 (1981).
23. McMillin, C. R., Saito, H, Ratnoff, O. D., and Walton, A. G., The secondary structure of human Hageman factor (factor XII) and its alteration by activating agents. J. Clin. Invest., 54(6), 1312-1322 (1974).
24. Radcliffe, R. Nemerson, Y. and Emerson, Y., Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J. Biol. Chem., 251(16), 4749-802 (1976).
25. Revak, S. D., Cochrane, C. G., and Griffin, J. H., The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. J. Clin. Invest., 59(6), 1167-75 (1977).
26. Revak, S. D., Cochrane, C. G., Johnston, A. R. and Hugli, T. E., Structural changes accompanying enzymatic activation of human Hageman factor. J. Clin. Invest., 54(3), 619-27 (1974).
27. Rob, F., Van, R., Joa, C. B., Donald, M. S., Johan, D. and Jan. A. V. M., Bradykinin-mediated hypotension after infusion of plasma-protein fraction. J. Lab. Clin. Med., 100, 288-295 (1982).
28. Siv, F., Nils-Ove, H., Halvard G. and Kjell, B., Contact activation factors in plasma from women on estrogen replacement therapy after ovariohysterectomy. Thrombosis Research, 93, 161-170 (1999).
29. Snape, T. J., Griffith, D., Vallet, L. and Wesley, E. D., The assay of prekallikrein activator in human blood products. Develop.Biol. Standard, 44, 115-120 (1979).
30. Tankersley, D. L., Fournel, M. A. and Schroeder, D. D., Kinetics of activation of prekallikrein by prekallikrein activator. Biochemistry, 19, 3121-3127 (1980).
31. Turner, P. J., Young, I. F., Marley, P. B., Herrington, R. W. and Schiff, P., Albumin solutions- Their production and quality control. Develop. Biol. Standard, 67, 119-127 (1987).
32. World Health Organization Technical Report Series. Control of albumin and plasma protein fraction. No. 840, Annex 2, Part B. 14. pp. 80-85 (1994).
33. Yasda, J., Ueno, G., Kuratsuka, K., Homma, R., Hara, S., Kazama, M. and Ito, H., Japanese minimum requirements for albumin preparations: recent amendments and current problems. Develop. Biol. Standard., 48, 143-152 (1981).